Study Of MK-0752 In Combination With Tamoxifen Or Letrozole to Treat Early Stage Breast Cancer (MK-0752)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00756717
Recruitment Status : Active, not recruiting
First Posted : September 22, 2008
Last Update Posted : April 3, 2015
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Kathy Albain, Loyola University

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : May 2015
  Estimated Study Completion Date : May 2018

Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 March 8, 2018